![Travis Murdoch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Travis Murdoch
Nessuna posizione attualmente
Patrimonio netto: 168 M $ in data 30/09/2026
Profilo
Travis Murdoch was the founder of HIBio, Inc. (founded 2021) serving as Chief Executive Officer & Director.
Dr. Murdoch is the founder of Monograph Capital Advisors (UK) LLP (founded 2021) serving as Partner.
Dr. Murdoch was the founder of Human Immunology Biosciences, Inc. (founded 2021) serving as Chief Executive Officer & Director.
Dr. Murdoch is the founder of Ollin Biosciences, Inc. (founded 2022) serving as Director.
Current jobs include President, Chief Executive Officer & Director at Braveheart Bio, Inc. starting 2025, and Director at Svf Excalibur Cayman Ltd. starting 2020.
Former jobs include Director at Karius, Inc. from 2020 to 2023; Director at Guardant Health AMEA, Inc. from 2019 to 2022; Independent Director at Zymergen, Inc. from 2020 to 2022; Consultant at McKinsey & Co., Inc. from 2015 to 2017; Principal at Third Rock Ventures LLC from 2017 to 2018; and Advisor at SB Investment Advisers (UK) Ltd. from 2021 to 2022.
Education includes graduate degree from the University of Oxford conferred in 2008, and undergraduate and doctorate degrees from the University of Alberta conferred in 2004 and 2009 respectively.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
9,26% | 07/08/2026 | 8.333.637 ( 9,26% ) | 168 M $ | 30/09/2026 |
Posizioni attive di Travis Murdoch
| Società | Posizione | Inizio |
|---|---|---|
Svf Excalibur Cayman Ltd. | Direttore/Membro del Consiglio | 29/07/2020 |
Monograph Capital Advisors (UK) LLP
 Monograph Capital Advisors (UK) LLP Investment ManagersFinance Monograph Capital invests in companies located in the United Kingdom. The firm targets companies operating in the fields of the biotechnology and healthcare sectors. It provides financing for early and growth stage capital requirements. | Fondatore | 01/01/2021 |
Precedenti posizioni note di Travis Murdoch
| Società | Posizione | Fine |
|---|---|---|
Human Immunology Biosciences, Inc.
 Human Immunology Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing therapies for immune-mediated diseases | Fondatore | 01/05/2024 |
Karius, Inc.
 Karius, Inc. Medical/Nursing ServicesHealth Services Operates as a clinical metagenomics that focused on elevating patient care through microbial insights | Direttore/Membro del Consiglio | 01/01/2023 |
| ZYMERGEN INC. | Direttore/Membro del Consiglio | 01/10/2022 |
SB Investment Advisers (UK) Ltd.
 SB Investment Advisers (UK) Ltd. Investment ManagersFinance Softbank Vision invests in technology companies across the Globe. The firm acquires minority and majority interests in both private and public companies with a minimum investment size of $100 million. | Consulente / Consigliere | 31/01/2022 |
Guardant Health AMEA, Inc.
 Guardant Health AMEA, Inc. Medical/Nursing ServicesHealth Services Provides health care services | Direttore/Membro del Consiglio | 31/01/2022 |
Formazione di Travis Murdoch
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
94
Relazioni di 1° grado
12
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 12 |
|---|---|
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Alberta
 University of Alberta Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It provides financing for early stage capital requirements. The firm also acts as lead investor. | Finance |
Zymergen, Inc.
 Zymergen, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that designs and develops genomics products | Health Technology |
SB Investment Advisers (UK) Ltd.
SB Investment Advisers (UK) Ltd. Investment ManagersFinance Softbank Vision invests in technology companies across the Globe. The firm acquires minority and majority interests in both private and public companies with a minimum investment size of $100 million. | Finance |
Karius, Inc.
Karius, Inc. Medical/Nursing ServicesHealth Services Operates as a clinical metagenomics that focused on elevating patient care through microbial insights | Health Services |
Guardant Health AMEA, Inc.
Guardant Health AMEA, Inc. Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
Svf Excalibur Cayman Ltd. | |
HIBio, Inc.
 HIBio, Inc. BiotechnologyHealth Technology Develops transformative therapies | Health Technology |
Monograph Capital Advisors (UK) LLP
Monograph Capital Advisors (UK) LLP Investment ManagersFinance Monograph Capital invests in companies located in the United Kingdom. The firm targets companies operating in the fields of the biotechnology and healthcare sectors. It provides financing for early and growth stage capital requirements. | Finance |
Human Immunology Biosciences, Inc.
Human Immunology Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing therapies for immune-mediated diseases | Health Technology |
